| In 2004-6 he worked with one of Norway’s leading private equity funds, FSN Capital in Oslo, as an Investment Manager. In 1998-2004 he was with UBS Investment Bank in London as a Corporate Finance adviser to large European companies and investment institutions. He holds a M.Sc. from the Stockholm School of Economics with exchange studies at the MBA program of New York University, Leonard N. Stern School of Business. |
| Mathias Karlsson (member since 2007) The inventor of the Calmark method. Responsible for the medical development of the method and CEO of Calmark Sweden AB. Mathias is an M.D. and holds a Ph.D. at Karolinska Institutet, Sweden, within the field of perinatal asphyxia and the unique properties of specific cell damage markers that indicate the physiological status of conditions caused by an insufficient oxygen supply in tissue. |
|
| Kent R Olsson (member since 2008) Business development advisor. Business broker and consultant in corporate and marketing strategy issues, especially for businesses in early development. For two and a half years, Kent was the CEO of Sahlgrenska Science Park, Gothenburg, and was responsible for the build-up of the organization. Kent was one of the founders of Neoventa Medical and the CEO during the build-up of the company, in total six years. He has many years of executive management experience from the international pharma and medical-technology industry. Kent has held executive positions both in Sweden and internationally. |
|
| Mats Herdenfeldt (member since 2009) Mats is a Senior Advisor in corporate finance, turn arounds and business process re-engineering. He has held CEO positions at Data General Nordic Area, NETnet Europe (Telecoms), Danzas 3PL Europe North among others. He has also worked as Corp Product Marketing Director at Data General Inc. in the US. Mats has an extensive experience through seats in over twenty boards. |
|
| Måns Olsson (member since 2010) Måns is Senior Vice President of business development at Diaverum, a renal care provider with operations in Europe, Latin America and Australia. At Diaverum he is in charge of strategy, M&A and new product lines. Previously, Måns was part of Philips’ global corporate strategy team and worked with sales and marketing for Mölnlycke Health Care in Singapore. He started his career as a management consultant with McKinsey & Co. in Gothenburg, Sweden and Singapore. Måns holds a M.Sc. from the Gothenburg School of Economics. |
|
| Peter Sjöstrand (member since 2010) Peter is former CFO and Executive Vice President of Astra AB. Peter is a board member of Active Biotech AB, Oscar Hirsch Memory Foundation, Karolinska Development AB and School of Technology and Health (Royal Institute of Technology), Former Chairman of, inter alia, Meda AB and Gambro AB, and former board member of, inter alia, Swedish leading chain of clinics Aleris AB. Peter holds a B.Sc. from the Stockholm School of Economics and an MD from the Karolinska Institutet, Sweden. |
|



